Clinical Trials Sponsored by Fortis Healthcare

Total 5096 results

Fortis Therapeutics, Inc.

Completed

A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Prostate Cancer Metastatic

United States
Fortis Therapeutics, Inc.

Completed

A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

Multiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed Remission

United States
Fortis Hospital, India

Unknown

Can Changes in Velocity Time Integral Serve as a Sensitive Indicator for Monitoring Changes in Stroke Volume ?

Ischemic Heart Disease
HealthCore-NERI
Bayer; Besins Healthcare

Completed

Registry of Hypogonadism in Men (RHyMe)

Male Hypogonadism | Testosterone Deficiency | Androgen Deficiency

Italy, United Kingdom, Spain, Netherlands, Germany, Sweden
Cordis Corporation
Quintiles, Inc.; HealthCore-NERI

Completed

A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft® Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INSPIRATION) (INSPIRATION)

Abdominal Aortic Aneurysm

United States, Japan
Fortis Memorial Research Institute

Terminated

Radiation- Induced Alopecia in Patients Undergoing Radiation Therapy to the Brain

Alopecia; X-Rays

India
Forbes Norris MDA/ALS Research Center
Muscular Dystrophy Association

Completed

A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS) (Lithium)

Amyotrophic Lateral Sclerosis

United States
Fortius Clinic

Unknown

Functional Improvement and UTC of the Achilles Tendon After Sodium Hyaluronate Injection for Plantaris Syndrome

Non-Insertional Achilles Tendinopathy | Plantaris Friction Syndrome

United Kingdom
Fortius Clinic

Unknown

Plantaris Release for Non-insertional Achilles Tendinopathy

Tendinopathy | Achilles Tendon

United Kingdom
Forbes Norris MDA/ALS Research Center
Muscular Dystrophy Association

Completed

Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org

Amyotrophic Lateral Sclerosis

United States
Kakatiya University
Fortis Hospital, India

Completed

A Prescription Audit of Inpatient Department of Super Speciality Hospital in National Capital Region of India

Review of In-patient Prescription

India
ortis
CEN Biotech

Completed

Study on the Effect of Rhubarb Extract on Stool Frequency and Biological Markers of Intestinal Function in Seniors With Low Defecation

Constipation - Functional

France
Samuel Fortin

Terminated

Impact of Fish Oil Monoglycerides on the Modulation of Mitochondrial Functions and Lactate Threshold

Healthy Athletes

Canada
Samuel Fortin

Completed

Effect of Fish Oil Monoglycerides on the Omega-3 Index

Pharmacokinetic in Normal Population

Canada
Fortis Hospital, India
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Clinical Outcome in High Risk Patients Who Received Empirical Antifungal Therapy

Antifungal Therapy

India
Cordis Corporation

Completed

European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INSIGHT)

Abdominal Aortic Aneurysms

United Kingdom, Netherlands, Ireland, Sweden, Germany, Italy, Spain, France
Cordis Corporation

No longer available

Compassionate Use of the Incraft® AAA Stent Graft System

Abdominal Aortic Aneurysm

United States
Cordis Corporation

Completed

S.M.A.R.T.® Nitinol Self-Expandable Stent in the Treatment of Obstructive Superficial Femoral Artery Disease (STROLL)

Superficial Femoral Artery Disease

United States
Cordis Corporation

Terminated

An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II) (NEVO II)

Atherosclerotic Coronary Artery Disease

Spain, Switzerland, Netherlands
Cordis Corporation

Completed

The Intra-Drug Eluting Stent (DES) Restenosis Study (CRISTAL)

Coronary Artery Disease

France
Cordis Corporation

Completed

The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent (SUPER SL)

Arterial Occlusive Diseases

Germany
Cordis Corporation

Completed

A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions (SCORPIUS)

Coronary Artery Disease

Germany
Cordis Corporation

Completed

Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions (3D)

Coronary Artery Disease

Brazil
Cordis Corporation

Completed

Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)

Coronary Artery Disease

United States
Cordis Corporation

Completed

The Study to Assess AMI Treated With Balloon Angioplasty. (TYPHOON)

Coronary Artery Disease

France, Germany
Cordis Corporation

Completed

The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions. (E-SIRIUS)

Coronary Artery Disease

Germany
Cordis Corporation

Completed

Protection From Pulmonary Embolism With the Permanent OptEase™ Filter (PROOF)

Pulmonary Embolism
Cordis Corporation

Completed

Distal Protection Combined With PTCA in AMI Patients (DIPLOMAT)

Coronary Artery Disease

France
Cordis Corporation

Completed

FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent

Coronary Artery Disease

Netherlands
University of Oxford
Imperial College Healthcare NHS Trust; Fortius Clinic; BUPA Cromwell Hospital...

Unknown

Predicting Osteoarthritis Risk Following Knee Injury. (KICK)

Osteoarthritis | Injury

United Kingdom
St. Joseph's Healthcare Hamilton
Peter Boris Centre for Addictions Research (PBCAR)

Recruiting

Deep rTMS for Depression in Older Adults (DIVINE)

Major Depressive Disorder

Canada
Cordis Corporation

Withdrawn

China Post-market Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INITIATION)

Abdominal Aortic Aneurysms

China
Cordis Corporation

Unknown

CYPRESS - CYPHER for Evaluating Sustained Safety

Coronary Artery Disease

United States
Cordis Corporation

Completed

Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary | Peripheral Arteriosclerosis

United States
Cordis Corporation

Completed

ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis Trial) EU (ECLIPSE)

Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary

Germany
Cordis Corporation

Terminated

French Post-Marketing Surveillance Survey (FR E-REGISTRY)

Coronary Artery Disease
Cordis Corporation

Completed

A Study of the Presillion Stent in de Novo Coronary Lesions (PRESILLION)

Coronary Artery Disease

Belgium
Cordis Corporation

Completed

NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions

Coronary Artery Disease

United States
Cordis Corporation

Completed

Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

Coronary Artery Disease

United States
Cordis Corporation

Completed

Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial (DESSERT)

Coronary Artery Disease

Italy
Cordis Corporation

Completed

The Study of the Crushing Technique Application Using SES in Coronary Bifurcations. (CACTUS)

Coronary Artery Disease

Italy
Cordis Corporation

Completed

Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)

Coronary Artery Disease

United States
Cordis Corporation

Completed

Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

Coronary Artery Disease

United States
Cordis Corporation

Completed

The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)

Coronary Stenosis
Cordis Corporation

Terminated

Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions (DECODE)

Peripheral Vascular Diseases

United States, China, Malaysia, India, Singapore
Cordis Corporation

Completed

The Study of the BX Velocity Stent in the Treatment of De Novo Artery Lesions. (C-SIRIUS)

Coronary Artery Disease
Cordis Corporation

Completed

The CYPHER™ Stent Study in Patients With Small de Novo Coronary Artery Lesions. (SVELTE)

Coronary Artery Disease

Switzerland
Cordis Corporation

Completed

The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study. (RAVEL)

Coronary Artery Disease

France
Cordis Corporation

Completed

Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy (SAPPHIRE)

Carotid Artery Disease
Cordis Corporation

Completed

Evaluation of Two Reduced Sirolimus Doses in Treatment of de Novo Coronary Artery Lesions (REDOX)

Coronary Artery Disease

Brazil

3

Subscribe